Literature DB >> 6281256

Protection by superoxide dismutase, catalase, and poly(ADP-ribose) synthetase inhibitors against alloxan- and streptozotocin-induced islet DNA strand breaks and against the inhibition of proinsulin synthesis.

Y Uchigata, H Yamamoto, A Kawamura, H Okamoto.   

Abstract

We have shown previously that alloxan and streptozotocin, two major diabetogenic agents, cause DNA strand breaks in rat pancreatic islets and stimulate nuclear poly(ADP-ribose) synthetase, thereby depleting intracellular NAD level and inhibiting proinsulin synthesis (Okamoto, H. (1981) Mol. Cell. Biochem. 37, 43-61; Yamamoto, H., Uchigata, Y., and Okamoto, H. (1981) Nature 294, 284-286). In the present study, superoxide dismutase and catalase, scavengers of radical oxygens, were found to protect against islet DNA strand breaks and inhibition of proinsulin synthesis induced by alloxan. The radical scavengers did not affect islet DNA strand breaks or inhibition of proinsulin synthesis induced by streptozotocin. On the other hand, compounds that inhibit islet nuclear poly(ADP-ribose) synthetase were found to protect against alloxan- as well as streptozotocin-induced inhibition of proinsulin synthesis. The poly(ADP-ribose) synthetase inhibitors were ineffective in protection against DNA strand breaks induced by the agents. These results may provide an important clue for elucidating the prevention of insulin-dependent diabetes as well as for understanding the cause of diabetes.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6281256

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

Review 1.  Does the mitochondrial DNA play a role in the pathogenesis of diabetes?

Authors:  K D Gerbitz
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

2.  Differential susceptibility of chick and mouse islets to streptozotocin and its co-relation with islet antioxidant status.

Authors:  Manisha A Modak; Savita P Datar; Ramesh R Bhonde; Saroj S Ghaskadbi
Journal:  J Comp Physiol B       Date:  2007-01-05       Impact factor: 2.200

3.  Renoprotective effect of lansoprazole in streptozotocin-induced diabetic nephropathy in wistar rats.

Authors:  Rupinder Kaur; Rupinder Kaur Sodhi; Neha Aggarwal; Jaspreet Kaur; Upendra K Jain
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-10-16       Impact factor: 3.000

4.  Effect of niacin/nicotinamide deficiency on the diabetogenic effect of streptozotocin.

Authors:  J R Wright; J Mendola; P E Lacy
Journal:  Experientia       Date:  1988-01-15

5.  Protective effect of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase, against streptozotocin-induced diabetes.

Authors:  P Masiello; T L Cubeddu; G Frosina; E Bergamini
Journal:  Diabetologia       Date:  1985-09       Impact factor: 10.122

6.  Comparative interactions of streptozotocin and chlorozotocin with DNA of an insulin-secreting cell line (RINr).

Authors:  B T Mossman; C M Ireland; M Filipak; S LeDoux; G L Wilson
Journal:  Diabetologia       Date:  1986-03       Impact factor: 10.122

7.  The immunocytochemical localization of superoxide dismutase in the enterocytes of the avian intestine: the effect of vitamin D3.

Authors:  W L Davis; J L Matthews; K Shibata; M Kipnis; G R Farmer; E Cortinas; J C Meiyr; D B Goodman
Journal:  Histochem J       Date:  1989-04

8.  Streptozotocin-resistant BRIN-BD11 cells possess wide spectrum of toxin tolerance and enhanced insulin-secretory capacity.

Authors:  Hui-Kang Liu; Jane T McCluskey; Neville H McClenghan; Peter R Flatt
Journal:  Endocrine       Date:  2007-09-29       Impact factor: 3.633

9.  Spontaneous glucose intolerance in the progeny of low dose streptozotocin-induced diabetic mice.

Authors:  T Linn; E Loewk; K Schneider; K Federlin
Journal:  Diabetologia       Date:  1993-12       Impact factor: 10.122

10.  DNA cleavage induced by glycation of Cu,Zn-superoxide dismutase.

Authors:  H Kaneto; J Fujii; K Suzuki; H Kasai; R Kawamori; T Kamada; N Taniguchi
Journal:  Biochem J       Date:  1994-11-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.